Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical & Experimental OncologyISSN: 2324-9110
Munoz-Garzon V Author
Subjects of specialization
Affiliation
Elderly, Cancer chemotherapy, Facial tumour, Endometrial cancer
Department Oncology and Radiotherapy, CHUVI, Vigo, Spain
Biography
Munoz-Garzon V was working in the Department Oncology and Radiotherapy, CHUVI, Vigo, Spain. He has more than 40 publications. His current research area related to osteoarthropathy. He was specialised in Facial tumour.
Publications
Case Report Subscription
Lack of Response to Vismodegib in a Patient with Advanced Basal Cell Carcinoma: A Case Report
Author(s): Rodríguez-Cerdeira C and Munoz-Garzon V
Purpose: Basal cell carcinoma (BCC), the most common type of skin cancer in humans, rarely progresses to locally advanced or metastatic BCC. The size, extent, and location of the lesion should be carefully considered when selecting a treatment option for patients with BCC.
Methods: Moreover, clinicians should review the potential for significant deformity and anticipated morbidity, when considering radiation therapy and surgery for treatment. Vismodegib, the first approved oral therapy for advanced BCC, is a treatment option that clinicians might consider for patients with BCC lesions that exhibit the clinical characteristics as described above.
Google Scholars / Researchers Sites
